ENVB vs. RDIV

Last updated Aug 1, 2026

ENVB (Enveric Biosciences Inc) is a stock, while RDIV (Invesco S&P Ultra Dividend Revenue ETF) is Mid Cap Value Equities fund tracking the S&P 900 Dividend Revenue-Weighted Index. Over the past 10 years, ENVB returned -74.71%/yr vs 11.30%/yr for RDIV. Their 0.16 correlation means their historical movements had little consistent relationship.

Performance

ENVB vs. RDIV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enveric Biosciences Inc (ENVB) and Invesco S&P Ultra Dividend Revenue ETF (RDIV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ENVB achieves a -56.75% return, which is significantly lower than RDIV's 22.74% return. Over the past 10 years, ENVB has underperformed RDIV with an annualized return of -74.71%, while RDIV has yielded a comparatively higher 11.30% annualized return.

ENVB

• 1D: 9.79%
• 1M: 8.28%
• 6M: -46.05%
• YTD: -56.75%
• 1Y: -88.62%
• 3Y*: -85.14%
• 5Y*: -84.44%
• 10Y*: -74.71%
• ALL TIME*: -72.66%

RDIV

• 1D: -0.32%
• 1M: 6.60%
• 6M: 17.44%
• YTD: 22.74%
• 1Y: 36.48%
• 3Y*: 19.58%
• 5Y*: 13.86%
• 10Y*: 11.30%
• ALL TIME*: 11.74%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ENVB Enveric Biosciences Inc	$156.43K	$152.33K	$428.69K
RDIV Invesco S&P Ultra Dividend Revenue ETF	$3.34M	$2.84M	$4.35M

ENVB vs. RDIV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ENVB Enveric Biosciences Inc	-56.75%	-94.37%	-72.43%	-37.50%	-95.53%	-37.16%	-34.51%	-48.17%	-94.37%	-52.38%
RDIV Invesco S&P Ultra Dividend Revenue ETF	22.74%	12.36%	15.17%	4.66%	7.16%	29.12%	-9.31%	22.62%	-4.78%	11.63%

Correlation

The correlation between ENVB and RDIV is 0.15, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.15
Correlation (3Y) Balances recent behavior with more history.	0.21
Correlation (5Y) Shows whether the relationship held over a longer period.	0.22
Correlation (10Y) Provides a long-term view across more market conditions.	0.16
Correlation (All Time) Calculated using the full available price history since Jan 4, 2016	0.16

Return for Risk

ENVB vs. RDIV — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ENVB

ENVB Risk / Return Rank: 14
ENVB Sharpe Ratio Rank: 21
ENVB Sortino Ratio Rank: 13
ENVB Omega Ratio Rank: 14
ENVB Calmar Ratio Rank: 4
ENVB Martin Ratio Rank: 15

RDIV

RDIV Risk / Return Rank: 95
RDIV Sharpe Ratio Rank: 94
RDIV Sortino Ratio Rank: 94
RDIV Omega Ratio Rank: 92
RDIV Calmar Ratio Rank: 97
RDIV Martin Ratio Rank: 96

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ENVB vs. RDIV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enveric Biosciences Inc (ENVB) and Invesco S&P Ultra Dividend Revenue ETF (RDIV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ENVB	RDIV	Difference
Sharpe ratio: Return per unit of total volatility	-0.51	2.61	-3.12
Sortino ratio: Return per unit of downside risk	-0.94	3.77	-4.71
Omega ratio: Gain probability vs. loss probability	0.88	1.45	-0.57
Calmar ratio: Return relative to maximum drawdown	-0.96	7.24	-8.21
Martin ratio: Return relative to average drawdown	-1.20	22.00	-23.21

ENVB vs. RDIV - Sharpe Ratio Comparison

The current ENVB Sharpe Ratio is -0.51, which is lower than the RDIV Sharpe Ratio of 2.61. The chart below compares the historical Sharpe Ratios of ENVB and RDIV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ENVB vs. RDIV - Drawdown Comparison

The maximum ENVB drawdown since its inception was -100.00%, which is greater than RDIV's maximum drawdown of -49.97%. Use the drawdown chart below to compare losses from any high point for ENVB and RDIV.

Drawdown Indicators

	ENVB	RDIV	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-49.97%	-50.03%
Max Drawdown (1Y) Largest decline over 1 year	-92.70%	-4.84%	-87.86%
Max Drawdown (3Y) Largest decline over 3 years	-99.75%	-17.91%	-81.84%
Max Drawdown (5Y) Largest decline over 5 years	-100.00%	-24.89%	-75.11%
Max Drawdown (10Y) Largest decline over 10 years	-100.00%	-49.97%	-50.03%
Current Drawdown Current decline from peak	-100.00%	-1.46%	-98.54%
Average Drawdown Average peak-to-trough decline	-86.25%	-5.80%	-80.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	74.21%	1.59%	+72.62%

Volatility

ENVB vs. RDIV - Volatility Comparison

Enveric Biosciences Inc (ENVB) has a higher volatility of 17.33% compared to Invesco S&P Ultra Dividend Revenue ETF (RDIV) at 4.00%. This indicates that ENVB's price experiences larger fluctuations and is considered to be riskier than RDIV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ENVB	RDIV	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.33%	4.00%	+13.33%
Volatility (6M) Calculated over the trailing 6-month period	100.97%	9.25%	+91.72%
Volatility (1Y) Calculated over the trailing 1-year period	175.72%	13.49%	+162.23%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	155.84%	17.41%	+138.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	163.84%	21.85%	+141.99%

Dividends

ENVB vs. RDIV - Dividend Comparison

ENVB has not paid dividends to shareholders, while RDIV's dividend yield for the trailing twelve months is around 3.45%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ENVB Enveric Biosciences Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
RDIV Invesco S&P Ultra Dividend Revenue ETF	3.45%	3.94%	4.08%	3.93%	3.44%	3.31%	4.93%	3.84%	4.32%	4.26%	2.20%	4.49%

Frequently Asked Questions

Can I hold both ENVB and RDIV in my portfolio?

ENVB and RDIV have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ENVB or RDIV?

ENVB has higher volatility (17.33%) compared to RDIV (4.00%). In terms of maximum drawdown, ENVB dropped -100.00% vs RDIV's -49.97%.

Which has better risk-adjusted returns?

RDIV currently has the higher Sharpe Ratio (2.61 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.